Register Login

Caribou Biosciences Inc (CRBU)

  • Event
  • Oct. 18, 2022, 13:00 UTC

(70% Positive) Caribou Biosciences, Inc. (CRBU) Announces Enrollment Update for reported Due to Patient Enrollment Issues, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Oct. 3, 2025, 9:24 a.m.

    📋 Caribou Biosciences, Inc. (CRBU) - Clinical Trial Update

    Filing Date: 2022-10-18

    Accepted: 2022-10-18 09:00:26

    Event Type: Clinical Trial Update

    Event Details:

    Caribou Biosciences Inc (CRBU) Announces Clinical Trial Update Caribou Biosciences Inc (CRBU) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: reported, Dosed
    • Diseases/Conditions: New York City
    • Clinical Stage: clinical trial, Phase 1
    • Collaboration: ANTLER

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: Caribou Biosciences Inc
    • CIK: 0001619856
    • Ticker Symbol: CRBU
    • Period End Date: 2022-10-18
    • Document Type: 8-K

Search

News categories